Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Guideline for PET/CT imaging of neuroendocrine neoplasms with <sup>68</sup>Ga-DOTA-conjugated somatostatin receptor targeting peptides and <sup>18</sup>F-DOPA.

Thumbnail
View/Open
Supporting information (63.31Kb)
Publication Date
2017-08
ICR Author
Oyen, Willem
Marsden,
Author
Bozkurt, MF
Virgolini, I
Balogova, S
Beheshti, M
Rubello, D
Decristoforo, C
Ambrosini, V
Kjaer, A
Delgado-Bolton, R
Kunikowska, J
Oyen, WJG
Chiti, A
Giammarile, F
Sundin, A
Fanti, S
Type
Journal Article
Metadata
Show full item record
Abstract
<h4>Purpose & methods</h4>Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using <sup>68</sup>Ga-DOTA-conjugated peptides, as well as <sup>18</sup>F-DOPA imaging for various neuroendocrine neoplasms.<h4>Results & conclusion</h4>The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with <sup>68</sup>Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
URL
https://repository.icr.ac.uk/handle/internal/1089
Collections
  • Radiotherapy and Imaging
Version of record
10.1007/s00259-017-3728-y
Subject
Humans
Neuroendocrine Tumors
Gallium Radioisotopes
Dihydroxyphenylalanine
Heterocyclic Compounds, 1-Ring
Peptides
Receptors, Somatostatin
Image Interpretation, Computer-Assisted
Tissue Distribution
Quality Control
Practice Guidelines as Topic
Positron Emission Tomography Computed Tomography
Research team
Translational Molecular Imaging
Language
eng
Date accepted
2017-05-09
License start date
2017-08
Citation
European journal of nuclear medicine and molecular imaging, 2017, 44 (9), pp. 1588 - 1601

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.